Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Arcus Biosciences Inc’s current trading price is -49.42% away from its 52-week high, while its distance from the 52-week low is 47.69%. The stock’s price range over this period has fluctuated between $6.50 and $18.98. The company, operating within the financial sector, had a trading volume of approximately 0.92 million for the day, which was noticeably lower than the average daily share volume of 1.17 million over the last 3 months.
The market performance of Arcus Biosciences Inc’s stock has been turbulent in recent times.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Arcus Biosciences Inc (RCUS) has experienced a quarterly decline of -2.14% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.02B and boasts a workforce of 627 employees.
Analyzing Trading Volume and Moving Average Trends
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for RCUS stands at 0.11. Similarly, the long-term debt-to-equity ratio is also 0.09.
RCUS Stock Price Performance Analysis
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. This year’s metric has recorded a Price decrease of -35.53%. However, over the past six months, we’ve seen a stronger performance of -37.82%. The price of RCUS fallen by 7.38% over the last 30 days. And in the last five days, it has surged by 5.15%.
